Merck (MRK) Q2 Pofits Drop 52%; EPS Tops Views But Sales Fall Flat
Tweet Send to a Friend
Drugmaker Merck & Co. (NYSE: MRK) posted a 52 percent drop in second-quarter profit Friday, due to higher costs across ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


